The Gaudium IVF share price made a steady entry into the secondary market, listing at a premium on debut. In the stock market today, where every IPO opening is closely watched, this healthcare listing stood out for a simple reason — it marked the entry of India’s fertility care segment into the public markets.
No noise. No overstatement. Just numbers speaking clearly.
Let’s walk through what happened.
Market Performance: Gaudium IVF Share Price Opens at ₹83
The company’s shares began trading at ₹83 per share on the National Stock Exchange (NSE).
Here are the key details:
- IPO Price Band: ₹75 to ₹79 per share
- Listing Price on NSE: ₹83
- Premium Over Upper Band: 5.06%
- Total Issue Size: ₹165 crore
- Subscription (Feb 20–24): 7.27 times
The stock also opened at ₹83 per share on the Bombay Stock Exchange (BSE).
After listing, the company’s total valuation stood at ₹604.13 crore.
In the stock market today, many IPOs either spike sharply or struggle at debut. Gaudium IVF took a measured route, entering at a moderate premium over its offer price.
Main News: Fertility Care Company Enters the Public Market
This listing carries significance beyond just the price movement.
Gaudium IVF has become the first fertility care company in India to access public markets. That’s a structural development for the healthcare segment.
The assisted reproductive technology space has seen growth over the years, but public participation was missing — until now.
For those tracking healthcare trends in the stock market today, this debut adds an entirely new vertical.
IPO Utilisation: Expansion and Debt Management
The company raised ₹165 crore through the IPO.
The fresh funds are allocated toward:
- Setting up 19 new IVF centres across India
- Repayment of certain outstanding debt
- General corporate purposes
Expansion is clearly central to the roadmap.
Increasing centre count from its existing network suggests the company is focusing on scaling operations across different states.
Business Model: Hub-and-Spoke Structure
Gaudium IVF operates using a hub-and-spoke system.
Currently, the company runs:
- 7 hubs
- 28 spokes
This structure allows centralized expertise at hubs, while spokes extend service reach into multiple locations.
The model supports broader coverage without replicating full infrastructure everywhere.
In the evolving healthcare landscape of the stock market today, operational efficiency often shapes long-term scalability.
Financial Performance: Strong Revenue and Profit Growth
Now to the numbers — because fundamentals matter more than listing-day excitement.
For the financial year ended March 31, 2025, Gaudium IVF recorded:
- Revenue from operations: ₹70.72 crore
- Profit After Tax (PAT): ₹19.13 crore
Comparing this with the previous year:
FY24 Performance
- Revenue: ₹47.89 crore
- PAT: ₹10.31 crore
Year-on-Year Movement
- Revenue increased from ₹47.89 crore to ₹70.72 crore
- Profit rose from ₹10.31 crore to ₹19.13 crore
Both revenue and net profit reflected growth during FY25.
In the stock market today, consistent earnings progression becomes an important data point once a company moves from private to public.
Post-Listing Valuation Snapshot
After shares began trading at ₹83, the company’s market capitalisation stood at ₹604.13 crore.
This figure reflects total equity valuation based on the listing price.
Market capitalisation is more than just a number. It determines where the company stands among small and mid-sized healthcare players in the listed space.
Subscription Details: Demand in Primary Market
During the IPO window from February 20 to February 24, the issue was subscribed 7.27 times.
This indicates the level of participation the public issue received during the application period.
However, once shares list, the focus shifts from subscription data to operational numbers — something the stock market today always prioritises.
Financial Snapshot Table
FY24 | 47.89 | 10.31 |
FY25 | 70.72 | 19.13 |
The difference between FY24 and FY25 is visible in both top-line and bottom-line performance.
Why Gaudium IVF Share Price Listing Matters?
The Gaudium IVF share price listing does more than add another ticker to trading screens.
It:
- Introduces fertility care into listed healthcare stocks
- Expands investor visibility into assisted reproductive services
- Brings financial transparency to the sector
Healthcare already holds a steady presence in the stock market today. With this entry, a specialized niche becomes accessible to public investors.
What Comes Next for the Company?
With plans to launch 19 additional centres, the company is positioning for network expansion.
Its existing structure of 7 hubs and 28 spokes offers a foundation. The fresh capital may strengthen geographical coverage.
As a listed company, quarterly results and operational updates will now shape how the Gaudium IVF share price behaves in the secondary market.
Summary: Gaudium IVF Share Price in Stock Market Today
Here’s a clear recap:
- Listed at ₹83 per share on NSE and BSE
- 5.06% premium over IPO upper price of ₹79
- ₹165 crore IPO
- 7.27x subscription
- Post-listing market cap: ₹604.13 crore
- FY25 Revenue: ₹70.72 crore
- FY25 PAT: ₹19.13 crore
- 19 new centres planned
In the stock market today, not every listing marks a sector milestone.
This one did.
The fertility care space now has a public face. The numbers are disclosed. Expansion plans are outlined. And the Gaudium IVF share price has officially entered the listed universe.
Source: Moneycontrol
Easy & quick
Leave A Comment?